Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial
Titel:
Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial
Auteur:
Palace, Jacqueline Wingerchuk, Dean M. Fujihara, Kazuo Berthele, Achim Oreja-Guevara, Celia Kim, Ho Jin Nakashima, Ichiro Levy, Michael Terzi, Murat Totolyan, Natalia Viswanathan, Shanthi Wang, Kai-Chen Pace, Amy Yountz, Marcus Miller, Larisa Armstrong, Róisín Pittock, Sean